In December, MNCM’s Measurement and Reporting Committee and its board of directors approved the slate of measures for public reporting in 2019. The measures listed on the 2019 slate are similar to last year with a few updates. First, the Controlling High Blood Pressure HEDIS measure will not be publicly reported in 2019 due to substantial changes to the measure specifications; public reporting will resume in 2020. In 2020, adolescents will be added to the suite of depression outcome measures reported in 2020 and the new Symptom Control During Chemotherapy measure will also be reported.
Read more: